For the Inventor, By the Inventor

Enter assignee name

Foster City, CA, United States of America

Sciclone Pharmaceuticals, Inc.

USPTO Granted Patents = 21

CIPO Patents = 4

EPO Patents = 7

Trademarks = 1

Forward Citations = 162

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Cynthia W Tuthill (7 out of 8 patents)

Alfred R Rudolph (7 out of 8 patents)

Luigina Romani (2 out of 11 patents)

4. Enrico Garaci (2 out of 14 patents)

5. Guido Rasi (2 out of 3 patents)

6. Francesco Bistoni (2 out of 6 patents)

7. Paolo Di Francesco (2 out of 2 patents)

8. David L Horwitz (2 out of 2 patents)

9. Milton G Mutchnick (2 out of 6 patents)

10. Paul B Chretien (2 out of 4 patents)

11. Robert S King (1 out of 3 patents)

12. Friedhelm Blobel (1 out of 2 patents)

13. Paolo Carminati (1 out of 37 patents)

14. Eric C Mossel (1 out of 1 patent)

15. Clarence J Peters (1 out of 2 patents)

21 patents: Sort by Forward Citations

1. 9724395 - Treatment of cancer with immune stimulators (2017-08-08),

2. 8716012 - Alpha thymosin peptides as vaccine enhancers (2014-05-06),

3. 8389680 - [object Object] (2013-03-05),

4. 8207294 - [object Object] (2012-06-26),

5. 8193152 - Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds (2012-06-05),

6. 8163702 - Treatment of melanoma (2012-04-24),

7. 8029799 - Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma (2011-10-04),

8. 7906486 - Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa (2011-03-15),

9. 7897567 - Methods of protecting against radiation damage using alpha thymosin (2011-03-01),

10. 7297676 - Thymosin alpha 1 peptide/polymer conjugates (2007-11-20),

11. 7208167 - Treatment of hepatitis C with thymosin and peptide combination therapy (2007-04-24),

12. 7173013 - Treatment of tuberculosis using immunomodulator compounds (2007-02-06),

13. 6495521 - Combination therapy method for treating chronic hepatitis B (2002-12-17),

14. 6462017 - Method of reducing side effects of chemotherapy in cancer patients (2002-10-08),

15. 6288033 - Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir (2001-09-11),

SciClone Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of cancer and various other diseases. With a strong emphasis on China, the company aims to provide innovative and cost-effective medicines to improve patients' lives. SciClone is committed to conducting business ethically and strives to make a positive impact on global healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#25 in Foster City, CA

#3,626 in California

#15,181 in US

#29,079 in the World

Foster City, CA, United States of America

Sciclone Pharmaceuticals, Inc.

Forward Citations = 162

31 inventors:

Cynthia W Tuthill (7 out of 8 patents)

Alfred R Rudolph (7 out of 8 patents)

Luigina Romani (2 out of 11 patents)

4. Enrico Garaci (2 out of 14 patents)

5. Guido Rasi (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…